香港, 2025年4月2日 - (亞太商訊 via SeaPRwire.com) - 洲際航天科技集團有限公司（USPACE，HKEX: 01725）在最新發佈的2024年度業績公告中顯示，截至2024年12月31日止，洲際航天科技集團持續經營業務收益約為人民幣3.16億元，同比下降32.7%。這一數據反映出在全球經濟壓力及市場需求轉變的背景下，公司業績面臨一定挑戰。然而，公司在控制成本和推動技術創新方面取得了積極進展。在毛利方面，集團錄得約48.1百萬元，同比下降11.4%，這主要是由於原材料價格波動及生產成本壓力所致。 更值得關注的是，儘管市場環境艱難，但公司股東應占虧損錄得約1.98億元，同比較去年有所收窄（收窄約6.2%），這顯示管理層在費用控制、流程優化和資本管理上已採取有效措施，逐步改善財務狀況與資金壓力。雖然面臨全球市場環境複雜及外部經濟挑戰，但公司仍在技術創新與市場佈局上持續發力，力圖鞏固在衛星製造及電子製造服務（EMS）領域的領先地位。與國際宇航聯合會（IAF）攜手舉辦的「百顆衛星巡展」不僅展示了公司在先進技術研發與大規模生產方面的突破，還為全球客戶及合作夥伴提供了一個深入瞭解USPACE創新能力和未來規劃的絕佳平臺。百星展覽：技術與創新的盛宴USPACE與國際宇航聯合會（IAF）攜手舉辦的「百顆衛星巡展」在香港正式拉開帷幕，展覽展示了USPACE製造的100顆5米解析度光學衛星及其相關組件，並以「AI+精密製造」為核心理念，全面呈現了人工智慧技術與衛星製造、運營及應用的深度融合。USPACE通過整合Google DeepMind、Siemens Insights Hub、GPT、Deepseek、IoT + IBM Cloud以及PyTorch等多項尖端人工智慧技術，實現了衛星製造效率和精度的革命性提升。數據顯示，衛星製造成本降低了80%，生產效率提高了80%，這一突破性成果為航天工業樹立了新的標杆。全球化佈局與市場拓展USPACE的全球化佈局正在穩步推進。繼香港首站展覽後，百星巡展將在加拿大、美國、土耳其、阿聯酋、埃及、馬來西亞、泰國、法國、西班牙及巴西等多個國家展出。這一全球化的展示計畫不僅提升了USPACE的國際影響力，也為公司進一步拓展國際市場奠定了基礎。USPACE與阿拉伯資訊通訊組織（AICO）簽署了戰略合作協議，共同建設覆蓋非洲及中東地區的6000顆低軌衛星星座計畫。這一專案以"通信+遙感+導航增強"三位一體為核心架構，將首次實現手機直連衛星的大規模商用服務，旨在填補"一帶一路"國家的數字鴻溝，構建空天地一體化資訊網絡。這不僅是USPACE深度參與國際航天產業鏈的重要里程碑，也為其未來市場拓展提供了強勁動力。未來展望：AI重塑航天產業的無限可能展望未來，USPACE計畫在未來五年內憑藉其全球製造佈局與AI技術，成為全球最大規模、最低成本的近地軌道衛星製造商。公司目標是將年產能提升至700顆衛星，其中包括500顆5米解析度衛星、150顆1米解析度衛星及50顆0.5米解析度衛星。USPACE致力於將下一代「AI+精密製造」技術應用至更多領域，推動製造業創新與可持續發展。通過AI技術優化衛星能源系統和自主開發星載電腦系統，USPACE進一步提升了空間算力，同時降低了能源消耗。USPACE正在推動衛星具備自我學習與進化能力。通過構建天地一體化算力網路，USPACE將構建覆蓋太空與地面的分佈式AI算力池，為全球客戶提供更高效、更靈活的解決方案。這種人機協同的創新模式將進一步推動衛星製造行業的進步，提高生產效率和靈活性。在工業5.0的浪潮下，USPACE以"智能化、全球化、可持續化"為戰略支點，正引領全球航天產業邁向一個更高效、更互聯、更智能的新紀元。隨著全球對衛星通信、遙感、導航及深空探測需求的持續增長，USPACE有望在這一歷史性機遇中實現更大的突破。 Copyright 2025 亞太商訊 via SeaPRwire.com.
Hitachi’s New Corporate Vision: Changing the World and Future with the Power of Knowledge
TOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi High-Tech Corporation ("Hitachi High-Tech") has revised its corporate vision and mission effectivetoday.Corporate VisionChanging the World and Future with the Power of KnowledgeMissionWe provide solutions that will realize a sustainable society tomorrow through a deeper understanding of the issues facing society and ourcustomers todayWhile digitalization and development of AI and other technologies are rapidly accelerating, the future of thesocial environment surrounding us is uncertain due to increasing complexity and volatility caused by naturaldisasters, climate change, geopolitical risks and so on. Given this context, Hitachi High-Tech Group believesthat the crucial first step in changing the world and shaping the future is to deeply understand the rootcauses occurring around society and our customers, so that we can identify the hidden problems that areunrecognized by our customers and partners.Hitachi High-Tech has cultivated a variety of “Power of Knowledge” over the years, including Observation, Measurement, and Analysis technologies, global network, world-class products, and co-creative relationships with our customers and partners. By leveraging our "Power of Knowledge," eachemployee of Hitachi High-Tech Group will continue to provide solutions for the issues facing society andour customers today to realize a sustainable society tomorrow.About Hitachi High-Tech’s Corporate Vision and MissionSee here for more details. Corporate Vision: Hitachi High-Tech Corporation Copyright 2025 JCN Newswire via SeaPRwire.com.
Hitachi: Strengthening Our Analytical Business to Solve Social Issues with Our Core Technologies
Strengthening Our Analytical Business to Solve Social Issues with Our Core TechnologiesTOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi High-Tech Corporation ("Hitachi High-Tech") is strengthening its analytical businessthrough integrating and jointly operating its Hitachi High-Tech Analytical Science Ltd. ("Hitachi High-Tech Analytical Science") and Hitachi High-Tech Science Corporation ("Hitachi High-Tech Science") businesses.As of April 1, 2025, Hitachi High-Tech Science will become Hitachi High-Tech Analysis Corporation as part of this re-structure.By integrating the core technologies of both companies, we will be better equipped to address the increasingly complex processes involved in developing, manufacturing, and inspecting materials that our customers encounter. Bringing together X-ray fluorescence (XRF), optical emission spectroscopy (OES), laser induced breakdown spectroscopy (LIBS), thermal analysis (TA), liquid chromatography and spectrophotometers from Hitachi High-Tech Analytical Science and Hitachi High-Tech Science will facilitate the development of new, innovative solutions.Initiatives to create a safe and secure society, and reducing environmental impact are becoming increasingly important across a wide range of business fields including healthcare, semiconductors and electronic components, and batteries. The analytical division and beam technology division, which includes electron microscopes, are key to supportingHitachi High- Tech Group's Core Technology Solutions business. The Core Technology Solutions division leverages its expertise in Observation, Measurement, and Analysis to offer specialized solutions for measurement and inspection. These solutions support the R&D, manufacturing, and quality control processes, helping to address both customer and societal challenges.Whilst manufacturing processes are becoming more complex, waste reduction, circular economy and preservation of raw materials are key to a more sustainable, global industry.Hitachi High-Tech Group will use the “Power of Knowledge” it possesses to know accurately and leveraging deepunderstandings the genuine issues of society and customers, and we will contribute to create a sustainable society by solving these issues.About Hitachi High-Tech ScienceHitachi High-Tech Science supports a wide range of R&D and quality control operations through the development, manufacture, sale and maintenance of various analytical instruments for physical property analysis (thermal analysis,spectroscopy), elemental analysis (X-ray fluorescence, ICP, atomic absorption) and organic analysis (liquid chromatographs), along with the sale of related parts and consumables.About Hitachi High-Tech Analytical ScienceHitachi High-Tech Analytical Science, with locations in the UK, Germany, Finland and China, specializes in a widerange of connect materials analysis products and services for use in the lab or in-field. Our advanced, cutting-edge XRF,LIBS and OES solutions enable fast, accurate decisions during the production process whether they relate to raw material sourcing, quality control, end of life disposal or recycling.Contact:Osamu MatsuzawaBusiness Planning Department, Business Management Division Hitachi High-Tech Science CorporationE-mail: osamu.matsuzawa.wp@hitachi-hightech.com Copyright 2025 JCN Newswire via SeaPRwire.com.
Hitachi: Completion of New Production Facility for Semiconductor Manufacturing Equipment in Kasado Area
TOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi High-Tech Corporation announced that the new production facility for semiconductormanufacturing equipment (etch systems), which had been under construction since December 2023 in the Kasado area (Kudamatsu City, Yamaguchi Prefecture), was completed and started the operation on March 17, 2025.We aim to increase production capacity through digitalized and automated production lines in the new productionfacility. In addition, a comfortable work environment has been created with employee well-being taken into account, while achieving carbon neutrality through the use of renewable energy.Semiconductor-related markets are expected to continue to grow and expand due to increasing demand for generativeAI and autonomous driving in the future. With the start of the new production facility's operation, we will continue tocreate new value and solve customers’ issues by shortening development periods, reducing costs, and improving productivity.Hitachi High-Tech will continue to pursue and create new value together with our customers in order to contribute to sustainable industrial development that supports cutting-edge manufacturing and digital society, and to the realization of a sustainable society by solving social issues.About Hitachi High-TechHitachi High-Tech, headquartered in Tokyo, Japan, is engaged in activities in a broad range of fields, including manufacture and sales of clinical analyzers, biotechnology products, radiation therapy systems, semiconductor manufacturing equipment, analytical instruments, and analysis equipment. Also, we provide high value-added solutions in industrial fields such as mobility, connected, environment and energy, etc. Through business based on our core Observation, Measurement and Analysis technologies, we will contribute to the realization of a sustainable society by solving social issues.The company's consolidated revenues for FY2023 were approx. JPY 670.4 billion. For further information, visit https://www.hitachi-hightech.com/global/en/Contact:Kasado General Affairs Dept.,Human Resources & General Affairs Div., Hitachi High-Tech CorporationTel: +81-833-41-8704 Copyright 2025 JCN Newswire via SeaPRwire.com.
NEC has developed technologies that enable a secure workflow for personalized cancer vaccines and has proven their capabilities
TOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has developed and successfully demonstrated a technology that enables face recognition without storing patients' facial information and ensures traceability through the entire workflow process for personalized cancer vaccine. Moreover, NEC has developed and successfully demonstrated a new technology that requires minimal validation data to effectively manage sensitive information.This initiative marks a world-first accomplishment that is aligned with the practical workflow expected for personalized cancer vaccine therapies (1).Personalized cancer vaccines are developed by analyzing genomic data on a patient's tissue and blood samples, making accurate administration crucial since each vaccine is tailored to the individual. The workflow for these vaccines is more complex than that of conventional vaccines and is expected to expand as the number of patients increases. Therefore, integrating ICT into the workflow is essential to enhance safety and efficiency, facilitating the realization and widespread adoption of personalized cancer vaccine therapies.In addition to advancing personalized cancer vaccines through AI, NEC has also developed technologies to enhance vaccine manufacturing management. Furthermore, NEC has been actively involved in comprehensive ICT-based activities to produce personalized cancer vaccine therapies, including the publication of a white paper (2).NEC has now developed and demonstrated the following technologies for in-house PoCs.Workflow for Personalized Cancer Vaccines1. Biometric based digital signature that enables face recognition and ensures traceability without storing facial information (3)Since personalized cancer vaccines are developed based on patients' genomic data, they must be administered to the correct patient without any mix-ups, requiring highly reliable identification. In addition to verifying patients’ names and IDs, biometric recognition can further enhance identification reliability when collecting samples or administering vaccines. However, the use of biometric recognition requires the secure management of biometric information.NEC has developed a proprietary digital signature technology that enables face recognition without storing facial information. This is accomplished by converting the feature information of facial images into key information. This technology enables authentication using key information, enhancing the reliability of vaccine administration without the risk of misuse or leakage of sensitive facial information. In addition, the digital signature generated by this technology can be used to verify and trace the correct patient identification at the time of vaccine administration, without using facial information.Identification utilizing a biometric based digital signature2. Tampering detection technology that reduces the amount of validation data required to securely store sensitive informationSince personalized cancer vaccines are developed based on a patient's genomic data, ensuring the authenticity of the data is important. One solution is to use a tampering detection technology that attaches validation tag data to verify the genomic data. However, a large amount of genomic data and an enormous amount of tag data are required when large amounts of patient data need to be managed. Therefore, conventional tampering detection technologies face difficulties with tag data verification time and storage cost.NEC has developed a tampering detection technology that reduces the amount of validation tag data by grouping genomic data and assigning validation tags accordingly. This technology reduces the amount of tag data by 90% while maintaining the same level of tamper detection accuracy as the conventional methods of assigning tag data to each genomic data. Consequently, it lowers the storage cost of tag data while ensuring the authenticity of patient genomic data.Tampering detection for the genomic and vaccine data with minimal validation dataTo verify the capabilities of these technologies, NEC built an environment that simulates the actual workflow for personalized cancer vaccines. In tests that simulated mix-ups of patients or samples, it was confirmed that the biometric based digital signature technology can correctly detect a mix-up before a vaccine is administered, and that the tampering detection technology can detect if genomic data has been tampered with.Looking ahead, NEC will continue to approach the production of personalized cancer vaccine therapies from various perspectives, including further research and development based on these results.(1) According to an NEC survey as of April 1, 2025(2) NEC white paper proposes a comprehensive process workflow for the application of AI-driven personalized cancer vaccines: www.nec.com/en/press/202404/global_20240408_01.html(3) NEC develops biometric based digital signature technology that enables face recognition without storing facial information: www.nec.com/en/press/202502/global_20250226_03.html About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 JCN Newswire via SeaPRwire.com.
Mitsubishi Motors Launches Miland Virtual Car Lifestyle App Service
TOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced the launch of Miland, a virtual car lifestyle app that connects users and their friends, in the Japanese market(1) today. The app was developed in collaboration with JP UNIVERSE Inc.(2)In its mid-term business plan "Challenge 2025," Mitsubishi Motors has set creating seamless and efficient touchpoints with customers through digital transformation (DX) as a key strategy. The plan particularly focuses on Generation Z, who are digital natives and will become the core automotive purchasing and user group in 10 years, as well as business transformation and the creation of new businesses using digital technologies. To achieve this, open innovation, or co-creation, is positioned as a key measure, involving the development of new services through collaboration with a diverse range of people and technologies both inside and outside the company.The name of the service, Miland, is derived from the phrase “unexplored lands created by Mitsubishi Motors,” and was coined in the hope that people would discover new ways to enjoy cars in unexplored territories. It enables young people, particularly Generation Z, who do not own cars to experience the joy of having a car. In the virtual world, users can enjoy owning cars, driving with friends, and customizing their vehicles. Developed in collaboration with JP UNIVERSE, a group of creators specializing in immersive space services, the app offers a highly immersive and enjoyable experience.FeaturesEasily own cars in the virtual world- Users can own digital cars and garages, allowing for a simulated experience of car ownership. If converted to a Non-Fungible Token (NFT), the car becomes a personal asset, and can be bought and sold on the NFT marketplace(3) OpenSea, operated by Ozone Networks, Inc.Experience driving interactions with friends similar to social networking- Even when in different locations, users can communicate with friends as if they are driving together in the same space or vehicle. With map designs that offer unique virtual environments, users can drive along distinctive courses. It is also possible for users to drive together with a common mission.Customize cars in various ways- Cars can be customized by changing their color or adding stickers. Users can also personalize their cars with limited-time or mission-exclusive stickers. In addition, events and other special activities are planned for the future.Service introduction page (in Japanese only): https://relight-lab.mitsubishi-motors.com/milandtopTo expand the value of automobiles in line with the changing values of users brought about by digitization, Mitsubishi Motors has also launched the "Relight Lab" open innovation site today. This site will serve as a platform to implement new digital services, and seeks top runners in emerging technologies in the digital world as well as those skilled at building new digital services. By combining technology and ambition, the aim is to achieve open innovation, leading to the creation of new services from Mitsubishi Motors.Website (in Japanese only): https://relight-lab.mitsubishi-motors.com(1) The app is offered in Japanese and is available only in the Japanese market.(2) JP UNIVERSE Inc. (Representative: Hajime Tabata, CEO) was established on February 8, 2022. The company provides gamification platforms, game commerce, platform provision and operation, and XR production.(3) Available from early AprilAbout Mitsubishi MotorsMitsubishi Motors Corporation (TSE:7211) — a member of the Alliance with Renault and Nissan — is a global automobile company based in Tokyo, Japan, which has about 28,000 employees and a global footprint with production facilities in Japan and the ASEAN region. Mitsubishi Motors has a competitive edge in SUVs, pickup trucks and plug-in hybrid electric vehicles, and appeals to ambitious drivers willing to challenge convention and embrace innovation. Since the production of our first vehicle more than a century ago, Mitsubishi Motors has been a leader in electrification — launched the i-MiEV, the world’s first mass-produced electric vehicle in 2009, followed by the Outlander PHEV, the world’s first plug-in hybrid electric SUV in 2013. With a target of increasing the sales ratio of electrified vehicles to 100% by 2035, Mitsubishi Motors will deliver models that embody Mitsubishi Motors-ness and contribute to the realization of a carbon-neutral society.For more information on Mitsubishi Motors, please visit the company's website at www.mitsubishi-motors.com/en/ Copyright 2025 JCN Newswire via SeaPRwire.com.
Mitsubishi Corporation: Development of R&D Hub “iPark Kobe” in Kobe Medical Industry City
TOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Corporation (MC), Mitsubishi Corporation Urban Development Co., Ltd. (MCUD), and iPark Institute Co., Ltd. (iPi) are pleased to announce our joint development of a new, rental-lab-type R&D facility in Kobe Biomedical Innovation Cluster (KBIC). The facility, which has been tentatively named "iPark Kobe," will augment progress being made in KBIC to establish a community based on institutions dedicated to research and development. MCUD signed an agreement today with Kobe's municipal authorities to purchase land for the facility's construction on Kobe Port Island, which is owned by Kobe City.Growth in semiconductors, medical treatment and other cutting-edge industries has accelerated in recent years, which has given rise to the formation of unique industrial zones due to the large number of R&D interests and related businesses. As a consequence, facilities engaged in research and development are rapidly becoming the epicenters of new communities.Kobe City began developing KBIC in 1998 to promote an accumulation of medical care-related entities, including R&D facilities, hospitals and private enterprises. Now boasting more than 350 resident organizations, KBIC has grown into one of the largest medical care industrial clusters in Japan, making it a leading example of MC's mission to position advanced industries at the core of its urban development work.The land-purchase agreement was reached due to KBIC being the ideal location for the first "iPark" drug-discovery and bioresearch facility to be established outside Japan's Shonan region. MC, MCUD and iPi all have strong track records when it comes to advanced-industry facilities.MCUD has a wealth of expertise in developing high-performance distribution warehouses and shared manufacturing and R&D centers, while iPi has demonstrated its management capabilities in operating the Shonan iPark science park.Our three companies look forward to combining our respective know-how and networks to develop and manage iPark Kobe in ways that will help Kobe City achieve its community-building mission in KBIC. We are committed to exploring ideas that can drive further innovation and lead to more large-scale urban development projects that are built around R&D facilities.Outline of the Project SiteThe site is located in Kobe Medical Industry City, the second phase of Kobe Port Island, and will be directly connected to Kobe New Transit Port Liner Keisan Kagaku Center Station by a connecting deck. It is accessible in about 16 minutes from Sannomiya Station, which is the city's largest shopping district and transportation node, and in about 6 minutes from Kobe Airport Station.Inquiry RecipientMitsubishi CorporationTelephone: +81-3-3210-2171 Copyright 2025 JCN Newswire via SeaPRwire.com.
Eisai to Divest Rights for Pariet in China to Peak Pharma
TOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest the rights for proton pump inhibitor Pariet® (generic name: rabeprazole sodium) in China to Beijing Peak Biology Pharmaceuticals Co., Ltd., a CBC Group-controlled company. Peak Pharma has commenced marketing activities, while Eisai will manage the transfer of manufacturing and marketing authorizations during atransition period.Under the terms of the agreement, Eisai will receive RMB725 million (approximately 15.7 billion JPY1) as contractual upfront payments, as well as the rights to receive a sales milestone payment. The upfront payments have already been recorded in the third quarter of Eisai’s fiscal year ending March 31, 2025.Eisai expects no changes to its consolidated financial forecast for the fiscal year ending March 31, 2025.Pariet is a proton pump inhibitor (PPI) discovered and developed by Eisai, approved in more than 100 countries and regions worldwide. Pariet was approved in China in 2000 and is indicated forgastrointestinal disorders including gastric ulcer, duodenal ulcer, and reflux esophagitis. With the conclusion of this agreement, Eisai believes that CBC Group’s proven 'investor-operator' approach and commitment to delivering quality healthcare to a wide range of patients will maximize the value of Pariet in China.The agreement will enable Eisai to strategically reallocate resources to other mid-to-long-term business growth areas so as to continue to make further contributions to address the diversified needs of, andincrease the benefits provided to, patients and their families.1 Exchange rate: 1 RMB = 21.67 JPY (as of December 31, 2024)About CBC GroupHeadquartered in Singapore, CBC Group is Asia's largest healthcare-dedicated asset management firm, with an AUMof US$9 billion. With a diversified, multi-product strategy, CBC Group is focused on platform-building, buyout, privatecredit and royalties, and real estate, across the healthcare space, including pharmaceutical, biotech, medical technology, and healthcare services. We are committed to creating lasting value by integrating global innovations andtalents. Partnering with the world's top entrepreneurs and scientists, our unique “investor-operator” approach has empowered leading healthcare companies to widen access to affordable medical care, catalyse innovations, and improve efficiencies in fulfilling unmet medical needs worldwide.For more information on CBC Group, please visit www.cbridgecap.com/. Connect with us on LinkedIn (CBC Group).Media Inquiries:Public Relations Department, Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2025 JCN Newswire via SeaPRwire.com.
力鴻檢驗2024年度業績穩步向上 AI驅動智啟檢測行業新時代
EQS 新聞 via SEAPRWire.com / 2025-04-01 / 18:16 UTC+8 [香港－2025年4月1日]國際知名檢驗檢測企業–中國力鴻檢驗控股有限公司（「力鴻檢驗」或「本公司」，連同其附屬公司統稱「本集團」；股份代號：1586.HK）欣然宣佈，受益於全球能源行業與TIC行業的穩健發展態勢及本集團良好的戰略指引，2024年本集團充分發揮於細分領域行業龍頭的優勢，把握業務發展機遇，持續擴張企業規模，員工數已逾3300人，輻射全球19個國家。本集團持續深化品牌公信力建設，不斷提升運營效率及核心競爭優勢，紥實推進了高質量發展。 業績穩步向上 海外收入攀升 2024年，本公司實現營收港幣1,263.1百萬元，同比增長12.9%；公司利潤達港幣126.0百萬元，同比增長3.2%；本公司擁有人應佔利潤達港幣82.7百萬元，同比增長3.4%，進一步鞏固行業龍頭的優勢。本集團持續深化全球化布局及多元化業務拓展，服務網絡由過往所覆蓋的亞太地區主要貿易港口及樞紐城市進一步輻射至多個新興市場，全球分支機構及專業實驗室達78個，涵蓋多達19個國家。本集團精準捕捉新興市場發展機遇，通過卓越的全球化服務能力先發性布局非洲、中東等新興市場，業務版圖多點開花，海外市場開拓業績斐然，海外收入持續攀升21.3%，2024年海外收入達港幣567.6百萬元，佔本集團總收入44.9%，為本集團業績增長注入強勁動力。 大宗業務碩果累累 專業服務能力及品牌公信力獲市場肯定 本集團以強大的綜合實力、卓越的技術能力和優秀的人才隊伍為支撐，已經成為多家交易所指定的檢驗機構。年內本集團持續新增期貨交易所的指定質檢機構資質，進一步夯實於大宗商品檢驗的豐富經驗與品牌公信力。2024年1月22日，上海期貨交易所指定本集團為其氧化鋁期貨指定檢驗機構。本集團繼成為上海期貨交易所的銅鋁鋅三大有色金屬品種的指定檢驗機構之後，又再次成為其新增品種氧化鋁期貨指定檢驗機構，本集團已逐步深化於有色金屬客戶中的品牌知名度。2024年6月14日，鄭商所增設本集團為其鐵合金期貨指定檢驗機構。充分體現了鄭商所對本集團大宗商品檢驗的豐富經驗及品牌公信力的高度認可。本集團檢驗檢測產品線不斷豐富，目前已成為碳酸鋰、鐵合金、工業矽的主力質檢機構。 截至目前，力鴻集團及其附屬公司已取得各大交易所的期貨指定質檢機構資質名單： 交易所 期貨品種 上海期貨交易所 銅、鋁、鋅、氧化鋁、鋁合金 大連商品交易所 焦煤、焦炭、鐵礦石 鄭州商品交易所 動力煤、矽鐵、錳矽 廣州期貨交易所 工業矽、碳酸鋰 上海國際能源交易中心 國際銅 聚焦AI驅動的創新技術革新 智啟檢測行業新時代 2024年內，本集團加速融入AI發展大潮，AI助力技術創新升級，引領行業發展。本集團在煤炭、大宗產品、煉化一體化、新能源及環境等業務線率先部署AI應用技術，引入光譜分析自動化前處理系統及AI視覺檢測裝置，大幅提升關鍵環節自動化率和數據復核效率。本集團在合作夥伴支持下建設「智慧檢測實驗室3.0」，開發檢測數據區塊鏈存證平台，客戶通過「力鴻智檢」系統可即時追蹤檢測進度、自主授權報告流轉，使服務回應速度大幅提升。通過AI應用等技術創新推動服務能力優化升級，持續提升頭部客戶服務能力，強化客戶黏性與市場競爭力，鞏固行業領先地位。 2025年本集團計劃完成AI系統的全球化部署，並將在建立跨境檢驗AI互認體系、開發碳排放AI核算模組及構建能源大宗商品品質預測模型等領域實現持續突破。中長期而言，本集團將以更大力度支持研發創新，持續推動AI、數字孿生、區塊鏈等技術在檢測技術、裝備、以及實驗室管理的深度應用，推動AI驅動的無人化檢測和實驗平台建設，打造「AI驅動、人機協同」的檢驗檢測新範式。 氣候變化業務再接再厲積極助力能源產業鏈綠色低碳轉型 作為北京碳市場最重要碳資產交易商之一，本年度與客戶合作碳資產交易規模擴大，幫助更多客戶低成本完成年度履約工作。本集團進一步提升全球化作業能力，年內承接多個海外碳資產項目，助力行業及客戶的低碳轉型可持續發展。隨著全球碳市場新規則逐步出台與明晰，市場規模有望放量增長，本集團將積極掘金海量市場，充分發揮本公司內部專家為全球新碳市場機制專家及本公司於客戶與政府中的品牌公信力與影響力。 中國力鴻檢驗控股有限公司主席兼行政總裁李向利先生表示：「今年我們於業績報告中首次發佈了致股東的一封信。我們深知本集團的穩健發展離不開所有股東的大力支持，我們也期望借這封信表達對一路支持公司的股東投資者的感謝。公司秉承長期可持續發展的核心理念，高度重視股東回報，未來亦會堅定維護股東利益，共享公司的經濟發展成果，為各方利益相關者創造長期價值。 此外，人工智能(AI)技術的迅速發展正在重塑全球經濟中長期格局，2025年，本集團堅定AI驅動企業發展的決心，將AI作為新技術應用重點，緊緊抓住AI產業發展的機遇。本集團全面擁抱AI時代，培養AI能力、整合AI資源，及持續推進AI進展，快速迭代、持續改進、不斷創新。通過AI與機器人等助力技術創新升級，加速業務場景的AI賦能，建立企業智能發展藍圖，爭取率先實現業內革新，再攀高峰，爭取為股東帶來更長遠優質的回報。」 -完- 關於中國力鴻檢驗控股有限公司 中國力鴻檢驗控股有限公司（股票代碼：1586.HK）2016年於港交所主板上市，作為國際領先檢驗檢測機構，公司專注於應對氣候變化及綠色低碳可持續發展綜合解決方案。公司於貿易保障、清潔能源、環境保護及氣候變化四個主要領域24x7小時為全球行業龍頭提供一系列檢驗、檢測及技術與諮詢一站式技術服務，賦能全球行業龍頭實現綠色低碳轉型。公司持續強化全球化網路佈局，服務網路由所覆蓋的亞太地區主要貿易港口及樞紐城市進一步輻射至南美和非洲新興市場，海內外分支機構及專業實驗室達78個。本集團始終將「ESG發展策略」作為「3+X」戰略的核心發展方向，通過(1)ESG-Friendly；(2)ESG+；及(3)ESG-Focused三個主要執行維度，來實現ESG發展策略，踐行企業社會責任，為產業的綠色低碳轉型及社會早日實現碳中和目標貢獻力量。 2025-04-01 此財經新聞稿由EQS Group via SEAPRWire.com轉載。本公告內容由發行人全權負責。瀏覽原文: http://www.todayir.com/tc/index.php
中國在台灣周邊展開大規模軍事演習 “`
(SeaPRwire) - 台灣，台北— 中國軍方週二宣布在周邊海域和空域舉行大規模演習，其中包括一個航空母艦戰鬥群，再次警告這個自治的島嶼民主政體不要尋求正式獨立。 根據中國人民解放軍東部戰區發言人施毅的說法，這次聯合演習包括海軍、空軍、地面部隊和火箭部隊，旨在「嚴厲警告和有力遏制台灣獨立」。 沒有宣布演習的行動名稱，也沒有事先發出通知。 中國認為台灣是其領土的一部分，必要時將以武力控制，而大多數台灣人贊成他們事實上的獨立和民主地位。 任何衝突都可能將美國捲入，美國在該地區維持一系列聯盟，並在法律上有義務將對台灣的威脅視為「嚴重關切」的問題。 台灣總統府在社群平台X上發布訊息表示：「中國公然的軍事挑釁不僅威脅台灣海峽的和平，也破壞了整個區域的安全，澳洲、紐西蘭、日本、韓國、菲律賓和南海附近的演習就證明了這一點。 我們強烈譴責中國的升級行為。」 南海指的是南中國海，中國聲稱幾乎完全擁有這條戰略水道。 中國海軍最近也在澳洲和紐西蘭附近舉行了演習，但沒有發出警告，迫使商業航班在最後一刻改道。 台灣國防部表示，在週一上午6點至週二上午6點的24小時內，追蹤到19艘中國海軍艦艇在台灣周邊海域活動。 該部門補充說，自週六以來一直在追蹤山東號航空母艦的動向，其航母編隊已進入台灣的防空識別區，這是軍方追蹤的自行定義區域。 中國經常派遣軍事資產進入該區域，中國不承認該區域，但台灣官員最近警告說，中國可能會以軍事演習為幌子發動突襲。 台灣國防部長顧立雄說：「我要說這些行動充分反映了（中國）對區域和平與穩定的破壞。」 顧立雄說，台灣已成立中央應變小組，以監測最新的演習。 在台北街頭，人們表示氣氛緊張，但他們更關心經濟和圍繞美國總統 Donald Trump 政府的發展。 該市天安母區的麵攤老闆林輝宗說：「中國共產黨花這麼多時間和精力在這些事情上，但大多數人並不怎麼關注。」 中國海警局發言人朱安欽表示，中國海警局週二也在台灣周圍進行「執法巡邏」。 這次演習距離北京向台灣派遣大量無人機和船隻的大規模演習僅僅兩週。 中國國務院台灣事務辦公室表示，這次演習是針對台灣強烈支持獨立的總統賴清德。 中國國務院台灣事務辦公室週二在一份聲明中說：「賴清德頑固堅持『台灣獨立』的立場，公然將大陸標記為『外國敵對勢力』，並提出了所謂的『17點策略……煽動反華情緒。』 我們絕不容忍或姑息這種行為，必須堅決反擊並嚴厲懲罰這些行動。」 3月中旬，台灣的賴清德提出了一項旨在加強台灣國家安全的17點戰略。 這些要點包括允許軍事法院審理間諜案件，並對申請永久居留的中國公民實施更嚴格的移民規定。 賴清德的言行似乎特別激怒了中國領導人習近平，他之前進行的恐嚇對台灣民眾沒有產生太大影響。 這些恐嚇行動的時間，通常是為了回應台灣獨立的表達，包括時任美國眾議院議長 Nancy Pelosi 的訪問。 中國人民解放軍還發布了一系列影片來宣傳其軍事演習，其中包括一段影片，其中他們將賴清德描繪成一種綠色寄生蟲，透過孵化較小的寄生蟲來「毒害」該島。 影片顯示賴清德的頭部在一個球狀綠色蠕蟲的身體上，一雙筷子將他夾起來，在台灣上方的火焰上烤他。 每天向該島派遣 ，試圖削弱台灣的防禦和士氣，儘管島上 2300 萬人中的絕大多數拒絕其對台灣的主權主張。 近年來，它加大了這些演習的範圍和規模，從派遣少數單獨的戰鬥機和偵察機，到派遣成群的飛機、無人機和船隻。 中國國防大學教授張弛在接受中國國家電視台採訪時表示：「解放軍組織海軍和空軍演練海陸打擊等科目，重點檢驗部隊從多個方向對台灣當局的一些關鍵目標實施精確打擊的能力。」 台灣和中國在76年前的內戰中分裂，但 自2016年以來，中國切斷了與台北的幾乎所有聯繫。 ___ Wu 從曼谷報導。 Christopher Bodeen 從台灣台北對本報導做出了貢獻。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
法官暫緩川普政府終止委內瑞拉人民臨時保護身份 (TPS) 的計畫
(SeaPRwire) - 舊金山報導 — 一位聯邦法官週一暫停了川普政府終止數十萬委內瑞拉人臨時法律保護的計劃，該計劃原定於一周後到期。 美國舊金山地區法官 Edward Chen 的命令，對於 35 萬名委內瑞拉人來說是一大寬慰，他們的臨時保護身份 (Temporary Protected Status, TPS) 原定於 4 月 7 日到期，此前國土安全部長 Kristi Noem 推翻了拜登政府授予的保護。 Chen 在裁決中表示，Noem 的行動「威脅到：對數十萬人的生活、家庭和生計造成無法彌補的損害，他們的生活、家庭和生計將受到嚴重破壞，使美國損失數十億美元的經濟活動，並損害美國各地社區的公共健康和安全。」 他表示，政府未能確定「繼續為委內瑞拉受益人提供 TPS 會造成任何實際的抵銷性損害」，並表示原告可能會成功地證明 Noem 的行動「未經法律授權、武斷且反覆無常，並且受到違憲敵意的驅使。」 Chen 法官由民主黨總統 Barack Obama 任命，他表示，由 National TPS Alliance 提起的訴訟中的命令適用於全國。Noem 還宣布將於 9 月終止另外約 25 萬委內瑞拉人的 TPS。 法官給予政府一周時間提交上訴通知，並給予原告一周時間提交暫停令，以暫停 50 萬名海地人的保護，他們的 TPS 保護將於 8 月到期。前任部長 Alejandro Mayorkas 已將所有三批人的保護延長至 2026 年。 “今天對這個國家的移民社區來說是個好日子，” National Day Laborer Organizing Network 的聯合執行董事 Pablo Alvarado 說。 他說，最初受益於 TPS 計劃的逃離飽受戰爭蹂躪的薩爾瓦多的人們，努力維持保護，這些保護擴展到包括烏克蘭、蘇丹和敘利亞等國家——更廣泛的社區必須繼續奮鬥。 “鼓起勇氣站出來說，‘我在這裡，我要為此奮鬥’，需要很大的勇氣，”Alvarado 說。“我們不會拋棄任何人。我們將為每個人而戰，因為每個人都應該得到。” The Department of Homeland Security 沒有立即回應置評請求。 美國國會於 1990 年創建了 TPS，以防止將人們驅逐到遭受自然災害或內亂的國家，如果國土安全部長認為其本國的條件不適合返回，則授權人們在美國生活和工作，期限最多為 18 個月。 這些逆轉是前民主黨總統 Joe Biden 領導下的移民政策的重大轉變，此前，共和黨總統 Donald Trump 及其高級助手加強了對反對他們的法官的攻擊，而移民問題是許多分歧的最前沿。 在上週一的聽證會上，TPS 持有者的律師表示，Noem 無權取消保護，並且她的行動部分受到種族主義的驅使。他們要求法官暫停 Noem 的命令，理由是對 TPS 持有者因擔心被驅逐出境和可能與家人分離而造成的無法彌補的損害。 代表 Noem 的政府律師表示，美國國會賦予了部長明確而廣泛的權力，可以對與 TPS 計劃相關的事項作出決定，並且這些決定不受司法審查。他們說，原告無權阻止部長的命令得到執行。 但 Chen 發現政府的論點沒有說服力，並表示 Noem 和 Trump 對委內瑞拉人的眾多貶損和虛假評論，將其描述為罪犯，表明種族仇恨是終止保護的動機。 “根據負面的群體刻板印象行事，並將這種刻板印象推廣到整個群體，是種族主義的典型例子，”他寫道。 拜登大幅擴大了 TPS 和其他臨時保護形式的使用，以制定和擴大在美國生活的合法途徑，同時暫停對非法入境者的庇護。 Trump 質疑一位聯邦法官的公正性，該法官阻止了他將委內瑞拉移民驅逐到薩爾瓦多的計劃，僅在他政府要求上訴法院撤銷該法官的命令前幾個小時，就提出了批評。 政府還表示，它正在撤銷對超過 53 萬名古巴人、海地人、尼加拉瓜人和委內瑞拉人的臨時保護，這些人自 2022 年 10 月以來通過另一條稱為人道主義假釋的法律途徑來到美國，拜登使用這種途徑的次數比以往任何一位總統都多。他們為期兩年的工作許可證將於 4 月 24 日到期。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
威斯康辛州最高法院競選的利害關係，以及Elon Musk為何牽涉其中
(SeaPRwire) - 共和黨在去年選舉中的壓倒性勝利將在星期二威斯康辛州最高法院的特別選舉中受到考驗。 這次選舉已成為美國歷史上最昂貴的一次，投資額接近 1 億美元，候選人包括唐納·川普支持的 Brad Schimel 和自由派支持的 Dane County 法官 Susan Crawford，他們將正面交鋒。 勝者將決定目前由自由派控制的法院的多數席位。 威斯康辛州選舉的影響可能會在全國範圍內感受到，因為該州最高法院將對從墮胎權到國會選區重劃等問題作出裁決，後者將特別影響美國眾議院的組成。 共和黨以 218 比 213 的微弱多數領先，目前有多個席位懸而未決。 佛羅里達州的另一次特別選舉——爭奪國家安全顧問 Michael Waltz、撰寫關於The Atlantic 總編輯 Jeffrey Goldberg 的文章之人，以及因追求檢察總長職位失敗而辭職的前眾議員 Matt Gaetz 的席位——已經使共和黨的控制權面臨風險。 X 的 Elon Musk (同時也是 Department of Government Efficiency (DOGE) 的負責人兼 CEO)，以及支持他的團體，已經捐贈了大約 2000 萬美元來支持 Schimel，Musk 甚至在星期天向兩名威斯康辛州選民發放了 100 萬美元的支票。 Musk 在星期天說：「如果 [威斯康辛州] 最高法院能夠重新劃分選區，他們將會以不公正的手段劃分選區，剝奪威斯康辛州共和黨的兩個席位。 然後他們將試圖阻止我們為你們，美國人民，所做的所有政府改革。」 威斯康辛州的選舉日是 4 月 1 日。 以下是您需要了解的資訊。 候選人是誰？ 威斯康辛州的選舉將決定這個搖擺州的法院的意識形態構成，該州在 2024 年選舉川普為總統，但在 2020 年投票支持前總統 Joe Biden。 Musk 支持 Schimel，他是威斯康辛州前任檢察總長，也是一位自稱的「頂級警察」。 他承諾「嚴厲打擊犯罪」，這是他的競選口號，並將自己定位為反對「全國各地將其激進議程置於法律之上的流氓法官」。 他也得到了川普的背書。 Schimel 的對手 Crawford 是一位巡迴法院法官，她說她競選是為了「保護威斯康辛州人民在憲法下的基本權利和自由」。 Crawford 曾任檢察官和私人執業律師，之前曾代表 Planned Parenthood of Wisconsin，她說她希望為保護受到右翼議程威脅的基本權利而奮鬥。 她受到四位現任威斯康辛州最高法院法官、美國參議員 Tammy Baldwin，以及 Wisconsin Education Association Council 和 Emily’s List 等組織的支持。 為什麼 Elon Musk 如此關心這次選舉？ Musk 在星期天的一次市政廳會議上稱這次選舉對「文明的未來」至關重要，他一直是這次選舉的主要貢獻者。 個人競選捐款只能達到 20,000 美元，但到目前為止，Musk 已經向威斯康辛州共和黨捐贈了至少 300 萬美元。 其他由 Musk 的資金推動的團體已經在這次選舉中貢獻了超過 2000 萬美元。 Crawford 一直公開批評這位億萬富翁的行為。 她說：「Elon Musk 真的很想為自己在威斯康辛州最高法院買一個席位。 他想在那裡安插一個他認為可以對其施加影響並接近的人。」 Tesla 目前正捲入一場關於經銷商許可證的訴訟，因為該公司的經銷商許可證在 2024 年被拒絕，原因是州法律禁止製造商擁有經銷商，。 該案件可能會提交到州最高法院。 Musk 真的在向選民發放 100 萬美元的支票嗎？ 星期天，Musk 向該州的兩名註冊選民發放了一百萬美元的支票。 Musk 首次在普選中使用了這種策略，如果選民在搖擺州註冊投票，他也會給予選民一次協助 。 選舉法專家當時認為，這種行為是非法的，因為聯邦法律禁止人們支付或接受付款以註冊投票。 威斯康辛州檢察總長 Josh Kaul 在星期五請求阻止 Musk 向選民發放巨額付款，但上訴法院駁回了他的請求。 George Soros 參與了這次選舉嗎？ 慈善家 George Soros 是一位著名的自由派捐助者，他經常成為右翼陰謀論的主題，他已經向該州的民主黨捐贈了 200 萬美元。 Musk 在星期天在威斯康辛州發表講話時被打斷，他將此歸咎於 Soros，稱「至少會有幾個 Soros 的特工出現在觀眾席中，這是不可避免的。」本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
TikTok禁令期限可能對該App的未來意味著什麼
(SeaPRwire) - 儘管總統 Donald Trump 在一月最後一刻出手相救，但在拯救該應用程式的最後期限逼近之際，前景仍然不明朗。 TikTok 擁有超過 1.7 億用戶，一直受到美國立法者的抨擊，原因是他們擔心數據隱私和國家安全。為了拯救該應用程式，Trump 給了該社交媒體網站到 4 月 5 日的時間進行資產剝離並尋找一家位於美國的母公司。 在 下，Trump 是尋求在美國禁止 TikTok 的主要力量。 但在勝選後，總統對該應用程式的態度 發生了轉變，認為這是他獲得年輕選民支持的原因之一。 「我們有很多潛在買家，」Trump 週日搭乘空軍一號時表示。「我希望看到 Tiktok 繼續存在。」Trump 表示，如果未能達成協議，他將延長最後期限。中國已表示不支持強迫出售 TikTok。 最新的爭執只是為保持 TikTok 在美國可用而進行的漫長法律戰中的最新進展。 2023 年，聯邦法官 推翻了在蒙大拿州禁止 TikTok 的努力，此前創作者對該州提起了訴訟。 TikTok 沒有立即回覆 TIME 的置評請求。 以下是需要了解的資訊。 目前誰擁有 TikTok？ TikTok 由其位於北京的母公司 ByteDance 擁有。 據 報導，該公司 60% 的股份由包括 Carlyle Group、General Atlantic 和 Susquehanna International Group 在內的投資者擁有。 剩下的 40% 由 ByteDance 員工和 ByteDance 的創始人分配。 TikTok 在中國大陸無法使用，總部位於洛杉磯和新加坡。 但其母公司必須遵守中國法律，因為它運營著其他影片優先平台，例如中國版的 TikTok 抖音。 因此，中國政府擁有其子公司抖音的「黃金股」，約佔該應用程式的 1%。 美國為何禁止 TikTok？ 國會通過了一項 TikTok 禁令，作為對外援助補充方案的一部分，理由是國家安全方面的考量。 立法者特別擔心該公司可能與中國政府分享數據，或以有利於外國政府的方式干預用戶的演算法。 中國國家安全法要求任何公司或組織與該國的國家情報工作合作。 參議院商業委員會主席 Maria Cantwell 在 中表示：「國會的行動並非為了懲罰 ByteDance、TikTok 或任何其他個別公司。」「國會的行動是為了防止外國敵對勢力進行間諜活動、監視、惡意行動、傷害脆弱的美國人、我們的軍人和婦女以及我們的美國政府人員。」 目前，美國政府擁有的任何設備上都不允許使用該應用程式。 自 2020 年以來，包括印度在內的其他國家/地區已禁止所有用戶使用 TikTok，而澳洲和加拿大也同樣禁止 TikTok 在聯邦政府發布的任何設備上運行。 Trump 可以做些什麼來延長最後期限？ 目前的 4 月 5 日截止日期是透過行政命令發布的。 Trump 可能會發布另一項此類命令來延長截止日期。 如果 TikTok 被禁，您還可以使用它嗎？ 上次該應用程式被禁時，美國用戶無法評論、分享或觀看任何影片。 「美國已頒布一項禁止 TikTok 的法律。 不幸的是，這意味著您目前無法使用 TikTok，」在 期間，灰色背景上顯示一條訊息。 即使在應用程式恢復後，在 2 月中旬之前，TikTok 也無法在 Apple 和 Google Play 商店下載。 目前尚不清楚另一個潛在的禁令是否會以與前一個禁令類似的方式運行。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
腦部植入物可將思緒轉化為言語 “`
` tags. Here's the translation: (SeaPRwire) - 科學家們開發出一種設備，可以將關於言語的想法實時轉換為口語。 儘管它仍處於實驗階段，但他們希望這種腦機介面有一天能幫助那些無法說話的人發聲。 一項新的研究描述了在一位 47 歲、四肢癱瘓且 18 年來無法說話的女性身上測試該設備的情況。 作為臨床試驗的一部分，醫生在手術過程中將其植入她的腦中。 該研究的共同作者 Gopala Anumanchipalli 在《Nature Neuroscience》期刊上週一發表的研究中表示，它「將她的說話意圖轉換為流利的句子」。 其他用於言語的腦機介面（BCI）通常在句子想法和電腦化口語之間存在輕微延遲。 研究人員表示，這種延遲可能會擾亂自然對話的流暢性，可能導致溝通不暢和沮喪。 堪薩斯大學言語與應用神經科學實驗室的 Jonathan Brumberg 說，這是「我們領域相當大的進步」，他沒有參與這項研究。 加州的一個團隊用電極記錄了這位女性在腦海中默默說話時的大腦活動。 科學家們使用在她受傷前用她的聲音建造的合成器，創造了她本來會說出的語音。 他們訓練了一個 AI 模型，將神經活動轉化為聲音單位。 加州大學柏克萊分校的 Anumanchipalli 說，它的工作原理類似於用於實時轉錄會議或電話的現有系統。 植入物本身位於大腦的言語中心，以便它正在傾聽，並且這些訊號被翻譯成構成句子的語音片段。 Anumanchipalli 說，這是一種「串流方法」，每 80 毫秒的語音塊（約半個音節）被發送到錄音機中。 Anumanchipalli 說：「它不是在等待一個句子結束，而是在即時處理它。」 Brumberg 說，如此快速地解碼語音有可能跟上自然語音的快節奏。 他補充說，使用聲音樣本「將是語音自然性的一項重大進步」。 雖然這項工作部分由 National Institutes of Health 資助，但 Anumanchipalli 說它沒有受到最近的影響。 在該技術準備好廣泛使用之前，還需要更多的研究，但如果有了「持續的投資」，它可能會在十年內提供給患者，他說。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
我們必須停止責怪受川普總統攻擊的Law Firms
(SeaPRwire) - 這個月，總統唐納·川普發布了行政命令，針對幾家大型律師事務所的業務，並對更多律師事務所的人力資源實務展開調查。有些人急於譴責那些因總統近期威脅而受害的律師事務所屈服於他的要求。然而，沒有足夠的焦點放在這項報復行為背後的真正行為者：川普。 三家被針對的律師事務所——Jenner & Block、WilmerHale 和 Perkins Coie——在法庭上挑戰了總統，並獲得了針對其各自行政命令的限制令。另一家律師事務所 Covington & Burling 對一項更有限的行政命令未採取任何行動，而另外兩家律師事務所 Paul, Weiss 和 Skadden Arps 與總統達成了表面上的和解，讓川普得以從威脅中退縮。正如 Paul Weiss 主席向他的同事表示，該事務所解決了一項對事務所的生存威脅，而沒有損害其政策或文化原則。這封信還透露，Paul Weiss 成為目標，是因為 Brad Karp 試圖團結其他主要事務所，以支持早期被針對的同行事務所。事實上，一些競爭對手事務所的反應恰恰相反，試圖從 Paul Weiss 律師和客戶那裡搶奪利益，因為他們感到 Paul Weiss 的脆弱。 與總統達成的「協議」包括提供大量關於退伍軍人權利、反猶太主義和促進法律體系公平等事業的公益法律工作。這些都是這些事務所長期支持的事業，而且金額僅佔這些事務所已經投入的公益工作的一小部分。此外，Karp 堅稱 Paul Weiss 的和解協議不包括對先前事務所參與或人力資源實務的譴責，也沒有對未來的代理，包括反對川普政府的代理，施加任何正式限制。這樣的交易似乎是安撫焦慮的主要客戶，並可能挖走頂尖律師的好方法。 在我們的法律體系中，衝突解決方案是在漫長而昂貴的訴訟與更快速的協商和解之間取得平衡。這個選擇取決於每一方的戰略地位。總統不太可能在挑戰他的行政命令的訴訟中獲勝。因此，他有動機以保全面子的方式退縮，而 Paul, Weiss 和 Skadden Arps 意識到了這一點。此外，正如我的耶魯大學同事在《華爾街日報》上寫道，快速達成和解的事務所擁有更大的企業交易業務，其客戶流失的風險也高於那些擁有更大訴訟業務的事務所。擁有不同商業模式的律師事務所會以不同的方式應對同樣的危機是可以理解的。由於律師事務所資產的易逝性以及事務所對其客戶和員工的信託義務，事務所可以在做出不同的商業選擇的同時，仍然光榮地確保其未來。 Wilmer Hale 持續的複雜情況進一步表明了 Paul Weiss 和 Skadden Arps 的和解協議為何具有吸引力。Wilmer Hale 獲得了禁令，但法官明確拒絕了關於安全許可的救濟，因為看到總統川普的行政權力需要持續的訴訟。如果客戶需要他們的律師具有安全許可，並且在代理方面存在一些緊迫性，那麼客戶可能會感到不舒服。 對 Paul Weiss 和 Skadden Arps 行為的攻擊錯失了真正的故事。總統的目標是攻擊幾乎所有代表或僱用那些在法庭上挑戰總統行為的主要律師事務所。值得注意的是，在他攻擊的事務所中，沒有像 Jones Day、Quinn Emanuel 和 Sullivan & Cromwell 這樣對川普友好的事務所。事實上，這個事件最令人不安的方面之一是，總統在與 Karp 談判時，曾向 Paul Weiss 的競爭對手 Sullivan & Cromwell 的聯合主席，即川普對其因偽造商業記錄而被判 34 項罪名的上訴的私人律師尋求建議。這種參與沒有受到更大的審查和批評，這真是非同尋常。 法律界的領導者可以借鑒其他領域的同行的經驗。在金融公司因 2001 年 9 月 11 日的襲擊事件而失去了他們的同事後，他們的競爭對手趕來提供援助。客戶沒有被竊取，人才也沒有從受襲擊影響最嚴重的事務所中被挖走。 同樣，在 2008 年的金融崩潰期間，頂級金融公司的領導者共同努力，為 TARP 計劃提供支持，即使這些公司在競爭中處於有利地位，可以利用其倒下的競爭對手。像 UPS 或 FedEx 這樣的競爭對手通常不會試圖從彼此的不幸中獲利，而是會在面臨運營失敗、勞資糾紛和其他中斷時，互相提供幫助。 當 2021 年，達美航空 (Delta Airlines) 對新的限制性投票法表示擔憂時，總統呼籲抵制達美航空。我致電美國航空 (American Airlines) 和聯合航空 (United Airlines) 的首席執行官，他們立即表示公開支持達美航空，並加入了一個為此目的而匆忙召開的聯盟。 企業界首席執行官的領導力對阻止未受挑戰的威權主義對美國民主制度的侵蝕產生了深遠的影響。法律行業與眾不同——而由此產生的聚光燈並不令人感到光榮。律師們虛偽地譴責那些達成和解的律師事務所，這是值得注意的，因為許多同樣的律師之前未能加入支持這些事務所免受總統攻擊的努力。相反，他們在這裡責怪受害者。 希望法律界的領導者能夠從其他領域更大膽的領導者那裡學習。已經有數十名法學院院長一致發聲譴責總統對律師事務所的攻擊，而像 Kaplan Hecker & Fink LLP 和 Gupta Wessler PLLC 這樣的小型事務所也發聲捍衛他們的大型競爭對手，建議提交「法庭之友」摘要。 週一，美國律師協會加入了對川普總統脅迫性黨派行政命令的譴責，這些命令攻擊這些律師事務所，而紐約市律師協會也譴責了這種對法治的攻擊。也許大型事務所可以出於開明的自身利益與小型事務所聯合起來。現在聽取他們客戶的意見也不會造成傷害。法律界在這個危險的時刻做出補救還不算太晚。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
阿茲海默症血液檢測或能預測晚期病情 “`
(SeaPRwire) - 近年來，已有兩種阿茲海默症藥物獲得批准，這為有罹患這種記憶力喪失疾病風險的人們帶來了越來越大的希望。但檢測這種疾病的方法仍然落後。更早的診斷意味著人們可以更早地利用這些藥物，因為藥物在早期最有效。 目前的檢測方法很棘手。PET等腦部掃描可以檢測到類澱粉蛋白斑塊，這是該疾病的標誌，但當這些斑塊形成時，人們的腦功能已經在下降。掃描也很昂貴，並非所有醫院都能提供。更靈敏地檢測類澱粉蛋白和tau蛋白（另一種與該疾病相關的蛋白質）的方法是分析脊髓液，但這需要進行痛苦且具有潛在危險的脊椎穿刺。美國食品藥物管理局（U.S. Food and Drug Administration）尚未批准針對這兩種蛋白質的血液測試——儘管它們已獲得該機構的突破性認定，這意味著隨著測試研究的完成，它們正在接受加速審查。 在一項發表於Nature Medicine的新 研究中，由聖路易斯華盛頓大學（Washington University in St. Louis）的一個研究小組領導的研究人員報告說，他們開發了一種血液測試，可以檢測一種與現有測試目標不同的tau蛋白形式，結果很有希望。他們表示，這種形式更能表明患者大腦中積累了多少有害蛋白質——而且這些水平與一個人的疾病嚴重程度相關。通過將血液測試的結果與腦部掃描的結果進行比較，該團隊確定血液測試對tau蛋白的讀數準確度為92%。 華盛頓大學（Washington University）神經學教授、該論文的資深作者蘭德爾·貝特曼（Dr. Randall Bateman）表示，患者大腦中同時存在類澱粉蛋白和tau蛋白對於診斷阿茲海默症至關重要。類澱粉蛋白斑塊需要數年才能形成，並且只有當足夠的蛋白質簇形成時，才會出現記憶力減退、意識模糊和迷失方向等症狀。一旦類澱粉蛋白聚集體形成，tau蛋白就會開始在大腦神經元內外異常發展。 在細胞外部，tau蛋白形成科學家們稱之為磷酸化tau蛋白的東西——這是目前測試可以檢測到的。但在大腦神經元內部，阿茲海默症患者體內的tau蛋白會進一步分解，並且不會像沒有阿茲海默症的人那樣呈現整潔的線性形式，而是會結晶化，形成一團類似於纏繞在一起的紗線的蛋白質。“Tau蛋白纏結與一個人的癡呆症狀最相關，”貝特曼說。“斑塊就像燃料，推動著我們[在患者身上]觀察到的許多變化。但直到大火被點燃，tau蛋白纏結蔓延開來，大腦才會真正崩潰。” 他說，結晶形式的tau蛋白與阿茲海默症相關的認知能力下降有更強的聯繫，因此檢測到這種形式的tau蛋白的最初跡象將有助於醫生識別出處於發展為更嚴重的記憶和認知問題邊緣的患者。“這是第一份關於血液中tau蛋白纏結標記物的報告，”他說。 2023年，貝特曼和他的團隊開發了 針對這種結晶形式tau蛋白的檢測方法，但用於脊髓液。由於脊椎穿刺的不便和風險，該團隊隨後專注於在血液中尋找相同的結晶tau蛋白的明顯跡象。經過仔細篩選各種血液標記物後，他們最終找到了它。“我們逐個分子、逐個原子地尋找[我們知道]存在的tau蛋白形式的確切結構，然後發現了這種與纏結的存在獨特相關的形式。” 貝特曼創立了一家名為C2N Diagnostics的公司，以製造這種檢測方法並提供給研究人員用於臨床試驗。基於血液的測試可以加速抗tau蛋白的阿茲海默症治療方法的開發，因為藥物開發人員可以相當快地確定他們正在測試的化合物是否對患者大腦中積累的tau蛋白量產生任何影響，只需一小瓶血液即可。“我們很多人認為，如果我們可以減緩或逆轉tau蛋白纏結的形成，那麼這是一個減緩或逆轉阿茲海默症的好策略，”貝特曼說。“[該測試]可以加速新療法的開發速度。” 擁有一種相對簡單的方法來追踪阿茲海默症患者體內的tau蛋白水平，還可以提供關於該疾病如何發展的新線索，並可能為藥物提供新的靶點。 目前尚不清楚神經元外部存在的磷酸化tau蛋白形式與細胞內部通常存在的結晶形式有何關係，但有可能在某個時候，磷酸化tau蛋白的積累會觸發神經元內部破壞性結晶tau蛋白的形成。另一個尚未解答的問題是，為什麼一些結晶tau蛋白的片段會進入神經細胞外部。了解這個過程可能會帶來控制tau蛋白的新策略，並可能減緩疾病的進程。“如果我們想要為患者提供更好的治療方法，”貝特曼說，“那麼我們必須了解導致該疾病的原因。”本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
Euro Manganese Announces Upsize to Previously Announced Financing of up to C$11.2m (A$12.3m) including a Private Placement with Eric Sprott
HighlightsDue to strong demand Euro Manganese has upsized the previously announced C$5.9m (A$6.5m) placement to C$9.8m (A$10.8m) and the condition to raise C$8m has been metEric Sprott, through 2176423 Ontario Ltd., confirms participation for C$3.0m (A$3.3m)European Bank for Reconstruction and Development subscription increased to approximately C$3.9m (A$4.2m)Share Purchase Plan ("SPP") for certain eligible ASX shareholders revised to up to A$1.5m (C$1.4m). Orion Resource Partners ("Orion") to fund any shortfall under the SPP for up to A$1.5mAnnual and special meeting of shareholders rescheduled to May 15, 2025Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - April 1, 2025) - Euro Manganese Inc. (TSXV: EMN) (ASX: EMN) (FSE: E06) (the "Company") today announced that, due to strong investor demand, the previously announced financing on March 6, 2025, including a placement in the Company (the "Placement") of common shares ("New Shares") and CHESS Depositary Interests ("New CDIs") (together, "New Securities"), has been upsized to up to C$9.8m (approximately A$10.8m)1 and the condition to raise C$8m has been met. Proceeds will be used to support ongoing development of the Chvaletice Manganese Project and customer engagements to secure additional offtake term sheets and strategic investments.All defined terms in this press release have the same meaning as set out in the March 6, 2025, press release, unless such terms are otherwise defined herein.Euro Manganese is pleased to report that Mr. Eric Sprott, through 2176423 Ontario Ltd., a corporation which is beneficially owned by him, has agreed to subscribe for 16,666,666 (PC - 83,333,330) New Securities for an investment of C$3.0m (approximately A$3.3m). The European Bank for Reconstruction and Development ("EBRD") has increased its investment to approximately C$3.9m (approximately A$4.2m). Additionally, the Company is reducing the previously announced Share Purchase Plan ("SPP") amount to up to A$1.5m (approximately C$1.4 m), subject to receiving regulatory approval from the TSX Venture Exchange ("TSXV") for the amount of units that form part of the SPP under the Equity Raising (defined below).As previously announced on March 6, 2025 and March 31, 2025, the Company undertook a consolidation of its existing securities, including all shares represented by CDIs on the Australian Securities Exchange ("ASX"), at a ratio of five (5) pre-consolidation shares to one (1) post-consolidation share (the "Consolidation"). Subscriptions for all New Securities in the Equity Raising will be completed on a post-Consolidation basis. For the avoidance of doubt, all references to New Securities, Warrants, Broker Warrants, Additional Warrants and all per Share or per CDI dollar figures in this news release are on a post-Consolidation basis. Pre consolidation figures ("PC") are shown in brackets.Martina Blahova, Interim CEO of Euro Manganese, commented:"We are extremely pleased with the robust support demonstrated by both our existing shareholders and new investors, including the notable participation of Mr. Eric Sprott. This strong response, alongside the continued support from EBRD and Orion, underscores the strategic significance of the Chvaletice Manganese Project to Europe's critical minerals independence and supply chain security, a conviction further reinforced by the recent designation of the Chvaletice Manganese Deposit as a Strategic Deposit by the government of the Czech Republic and the Project's recognition as a Strategic Project under the EU's Critical Raw Materials Act."Details of the Placement and the SPPThe Company has rescheduled the date of its Annual and Special General Meeting ("ASGM") from April 22, 2025, to May 15, 2025, where shareholders will be asked to approve the issuance of New Securities and Warrants to be issued under the Placement and the SPP (collectively referred to as the "Equity Raising"). The Company will file a management information circular in connection with the ASGM in due course in accordance with applicable securities laws. The Equity Raising, and all terms related thereto, remain subject to the approval of the TSX-V.Details of the PlacementThe Placement consists of an aggregate of 54,578,350 (PC -272,891,772) New Securities (comprised of 39,671,662 (PC -198,358,310) New Shares and 14,906,688 (PC - 74,533,462 New CDIs)) and 54,578,350 (PC - 272,891,772) Warrants for aggregate gross proceeds of C$9.8m (approximately A$10.8m)1 which will be subject to shareholder approval as required by Listing Rules 7.1, 10.11.1 and 10.11.4 of the ASX to be sought at the ASGM. Warrants issued in connection with the Placement will be exercisable any time prior to the date that is 18 months from the closing of the Placement and have an exercise price of C$0.225 (PC - C$0.045) per New Security.Included in the Placement are:(i) subscriptions are to be issued in excess of the number permitted under ASX Listing Rule 7.1, which includes:14,650,278 (PC - 73,251,410) New CDIs and 14,650,278 (PC - 73,251,410) Warrants subscribed for under the Placement led by the Joint Lead Managers (as defined below) for aggregate gross proceeds of A$2.9m (approximately C$2.6m);21,400,000 (PC - 107,000,000) New Shares and 21,400,000 (PC - 107,000,000) Warrants subscribed for by EBRD for gross proceeds of C$3.9m (approximately A$4.2m) (the "EBRD Subscription");18,063,331 (PC - 90,316,655) New Shares and 18,063,331 (PC - 90,316,655) Warrants subscribed for directly with the Company for gross proceeds of C$3.3m (approximately A$3.6m), which include 16,666,666 (PC - 83,333,330) New Shares and 16,666,666 (PC - 83,333,330) Warrants subscribed for by Mr. Eric Sprott, through 2176423 Ontario Ltd. a corporation which is beneficially owned by him, for gross proceeds of C$3.0m (approximately A$3.3m) (the "Sprott Subscription"); and(ii) subscriptions by related parties of the Company (consisting of directors of the Company and companies controlled by directors of the Company) for 464,741 (PC - 2,323,707) New Securities (comprised of 208,331 (PC - 1,041,655) New Shares and 256,410 (PC - 1,282,052) New CDIs) and 464,741 (PC- 2,323,707) Warrants for gross proceeds of C$83,000 (approximately A$91,200) ("Related Party Subscription"), which are subject to approval by the Company's shareholders as required by ASX Listing Rule 10.11.1 and 10.11.4.Since certain directors and management of the Company are expected to participate in the Related Party Subscription, the Conditional Placement is expected to be a related party transaction subject to Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company intends to rely on exemptions from the formal valuation and minority shareholder approval requirements provided under sections 5.5(a) and 5.7(1)(a) of MI 61-101 on the basis that participation in the Conditional Placement by such directors and management is not expected to exceed 25% of the fair market value of the Company's market capitalization, as calculated in accordance with MI 61-101.Updated Details of the Share Purchase PlanDetails of the SPP were announced on March 6, 2025. The SPP will be reduced to up to A$1.5m (approximately C$1.4m) (the "SPP Subscription"), subject to receiving regulatory approval from the TSXV for the units that comprise the SPP under the Equity Raising. The SPP will include 7,692,307 (PC - 38,461,535) New CDIs and 7,692,307 (PC - 38,461,535) Warrants exercisable any time prior to the date that is 18 months from the date of issue of the Warrants, with an exercise price of C$0.225 (PC - C$0.045) per New Security. Orion has agreed to fill any shortfall under the SPP (at the Equity Raising Price) up to a maximum of A$1.5 million. The New CDIs and Warrants issued under the SPP will also be subject to shareholder approval at the ASGM under ASX Listing Rule 7.1. The record date for the SPP remains the same as disclosed on March 6, 2025, and the rest of the indicative timetable has changed as set out below.The Company retains the right to accept applications for the SPP (in whole or part) at its absolute discretion (subject to applicable law including compliance with the ASX Listing Rules). The Company may also cancel the SPP if the Company's Board of Directors determines it is in the best interest of the Company, after considering the final amount of units approved by the TSXV for the Equity Raising.European Bank for Reconstruction and DevelopmentWith the Sprott Subscription, the Company has now successfully secured additional funding that will satisfy the EBRD condition that the Company raise at least C$8 million (A$8.8m), assuming the Company receives shareholder approval at the ASGM. EBRD has increased its subscription to C$3,852,000 (approximately A$4.2m) given the upsizing of the Equity Raising. Prior to the completion of the EBRD Subscription, EBRD owns 3,560,000 common shares, representing an ownership interest of 4.42% of the issued and outstanding common shares. On completion of the EBRD Subscription, EBRD's ownership interest will be, in aggregate (including the common shares it currently owns) 24,960,000 common shares, representing an ownership interest of 17.48% of the issued and outstanding common shares and an increase of 13.06%. Assuming the exercise by EBRD of all its Warrants, and assuming the exercise of (i) all Warrants issued under the Equity Raising, (ii) all Warrants issued under the SPP Subscription, and (iii) all Additional Warrants, EBRD's ownership interest will be in aggregate 46,360,000 common shares, representing an aggregate beneficial ownership interest of 19.96% of the issued and outstanding shares and an increase of 15.54%. EBRD has agreed, pursuant to the terms of the Warrants issued to EBRD, that for so long as the Company is listed on the TSXV, unless approval from the TSXV and disinterested shareholders of the Company have been obtained pursuant to the policies of the TSXV (provided that such approval is required at the relevant time), EBRD will not be permitted to exercise such number of warrants that would result in it beneficially owning more than 19.99% of the outstanding common shares of the Company.Broker Fees and Additional WarrantsCanaccord Genuity (Australia) Limited ("Canaccord Genuity") and Foster Stockbroking Pty Ltd ("FSB") are acting as Joint Lead Managers and Bookrunners for the Equity Raising (together the "Joint Lead Managers"). Aggregate fees payable in cash by the Company to Canaccord Genuity and FSB in connection with the Placement and the SPP will be 6% of the aggregate gross proceeds from the Placement and SPP to a cap of C$8 million (A8.8m).Additionally, Canaccord Genuity and FSB will be issued 4,904,478 (PC - 24,522,396) broker warrants ("Broker Warrants"), representing 12% of the aggregate number of New Securities issued under the Placement and the SPP, excluding those issued pursuant to the EBRD Subscription, exercisable any time prior to the date that is 24 months from the date of issue of the Broker Warrants, with an exercise price of C$0.225 (PC - C$0.045) per New Security. As the number of Broker Warrants, together with the New Securities and Warrants to be issued under the Placement, exceeds the maximum number of securities that can be issued by the Company under ASX Listing Rule 7.1, this issuance will also be subject to approval by the Company's shareholders at the ASGM.Additionally, as announced previously on December 3, 2024, the Company agreed, subject to receipt of TSX-V approval, to issue to Orion 22,263,733 (PC - 111,318,665) warrants to purchase Shares (the "Additional Warrants"), exercisable any time prior to the date that is 18 months from the closing of the Placement, with an exercise price of C$0.225 (PC - C$0.045) per New Security. As the number of the Additional Warrants exceeds the maximum number of securities that can be issued by the Company under ASX Listing Rule 7.1, this issuance will also be subject to approval by the Company's shareholders at the ASGM.The securities to be issued or made issuable under the Equity Raising, as well as the Additional Warrants, have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or any state securities laws and may not be offered or sold in the United States or to U.S. Persons absent registration or an applicable exemption from registration. This press release is not an offer or a solicitation of an offer of securities for sale in the United States, nor will there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.Applicable Hold PeriodsNew Shares issued or made issuable will not be permitted to be traded in or into Canada or through TSXV for 4 months and 1 day following completion and will be subject to legending requirements under Canadian securities laws. New Shares will be listed on the TSXV, and New CDIs listed on the ASX. Warrants will not be listed. New CDIs will not be permitted to be exchanged for common shares and traded on TSXV for 4 months and 1 day from their date of issue.Common shares issued upon exercise of the Warrants, Broker Warrants or Additional Warrants during the four-month period and 1 day after their respective date of issue are subject to the same restrictions noted above.The Warrants, Broker Warrants or Additional Warrants may not be traded in or into Canada for 4 months and 1 day following completion and will be subject to legending requirements under Canadian securities laws.Updated Indicative Equity Raising Timetable The following indicative timetable assumes A$1.5m SPP and is subject to the Company receiving TSXV approval for the amount of units that form part of the SPP under the Equity Raising. VancouverAustraliaSPP Record Daten/aWednesday, March 5, 2025Share Purchase Plan Opensn/aWednesday, April 16, 2025Share Purchase Plan Closesn/aWednesday, April 30, 2025Meeting to approve the Equity Raising and related mattersThursday, May 15, 2025Friday, May 16, 2025Settlement of New Securities Issued under the Equity RaisingWednesday, May 21, 2025Thursday, May 22, 2025Allotment of New Securities issued under the Equity RaisingThursday, May 22, 2025Friday, May 23, 2025 About Euro ManganeseEuro Manganese is a battery materials company focused on becoming a leading producer of high-purity manganese for the electric vehicle industry. The Company is advancing development of the Chvaletice Manganese Project in the Czech Republic and exploring an early-stage opportunity to produce battery-grade manganese products in Bécancour, Québec.The Chvaletice Project is a unique waste-to-value recycling and remediation opportunity involving reprocessing old tailings from a decommissioned mine. It is also the only sizable resource of manganese in the European Union, strategically positioning the Company to provide battery supply chains with critical raw materials to support the global shift to a circular, low-carbon economy.Euro Manganese is dual listed on the TSX-V and the ASX.www.mn25.caAuthorized for release by the Interim CEO of Euro Manganese Inc.Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) or the ASX accepts responsibility for the adequacy or accuracy of this release.EnquiriesMartina BlahovaInterim Chief Executive Officer+1 (604) 681-1010martina@mn25.caLodeRock AdvisorsNeil WeberInvestor and Media Relations - North America+1 (647) 222-0574neil.weber@loderockadvisors.comJane Morgan ManagementJane MorganInvestor and Media Relations - Australia+61 (0) 405 555 618 jm@janemorganmanagement.com.au Company Address: #709 -700 West Pender St., Vancouver, British Columbia, Canada, V6C 1G8Website: www.mn25.caForward-Looking StatementsCertain statements in this news release constitute "forward-looking statements" or "forward-looking information" within the meaning of applicable securities laws. Such statements and information involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of the Company, its Chvaletice Project, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. Such statements can be identified by the use of words such as "may", "would", "could", "will", "intend", "expect", "believe", "plan", "anticipate", "estimate", "scheduled", "forecast", "predict" and other similar terminology, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved.Readers are cautioned not to place undue reliance on forward-looking information or statements. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements and, even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company.Such forward-looking information or statements also include, but are not limited to, statements regarding the Company's intentions regarding the development of the Chvaletice Project, statements regarding the terms of the Placement, including completion thereof, the anticipated closing dates of the Placement, receipt of necessary regulatory approvals, the holding of the shareholder meeting, the use of proceeds of the Placement and the SPP, the issuance of the Additional Warrants, the terms of the SPP, including completion thereof, and any participation by Orion, statements regarding the Consolidation, including completion thereof.All forward-looking statements are made based on the Company's current beliefs including various assumptions made by the Company including that the Chvaletice Project will be developed and operate in accordance with current plans, that the Company will be able to raise the financing that it requires, and that it will meet conditions of its secured credit facility. Factors that could cause actual results or events to differ materially from current expectations include, among other things: risks and uncertainties related to maintaining necessary licenses or permits; risks related to acquisition of surface rights; securing sufficient offtake agreements; the availability of acceptable financing, and risks related to granting security; developments in EV (Electric Vehicles) battery markets and chemistries; and risks related to fluctuations in currency exchange rates, changes in laws or regulations; and regulation by various governmental agencies. For a further discussion of risks relevant to the Company, see "Risk Factors" in the Company's annual information form for the year ended September 30, 2024, available on the Company's SEDAR+ profile at www.sedarplus.ca.Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release and are expressly qualified in their entirety by this cautionary statement. Subject to applicable securities laws, the Company does not assume any obligation to update or revise the forward-looking statements contained herein to reflect events or circumstances occurring after the date of this news release.NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/246916 Copyright 2025 ACN Newswire via SeaPRwire.com.
Wuling Motors (00305.HK) Achieves a Surge of 115.6% in Net Profit Attributable to Shareholders for 2024
HONG KONG, Mar 26, 2025 - (ACN Newswire via SeaPRwire.com) - Wuling Motors (00305.HK), a leading manufacturer of automotive components and commercial vehicles assembly in China, announced its full-year results for 2024 on March 25. Driven by the increased proportion of sales from high-margin products in the automotive components and other industrial services division, Wuling Motors recorded a net profit of approximately 111 million yuan (RMB, same hereinafter) for 2024, representing a 60.2% year-on-year increase. The profit attributable to the owners of the company surged by 115.6% year-on-year to 50.62 million yuan.Core Business Growth Exceeds Expectations with Multiple Notable Breakthroughs in Incremental MarketsIn 2024, Wuling Motors achieved revenue of 7.95 billion yuan, with the automotive components and other industrial services division, the vehicles’ power supply systems division, and the commercial vehicles assembly division accounting for 69%, 22% and 9%, respectively.Specifically, the automotive components and other industrial services division recorded revenue of approximately 5.46 billion yuan. The increase in the proportion of high-margin product sales, coupled with higher government subsidies, led to an operating profit of approximately 154 million yuan, representing a 68.3% year-on-year surge.In 2024, Wuling Motors focused on deepening its existing business with its key customer - SAIC-GM-Wuling, while actively expanding externally. It successfully secured component supply transactions for multiple new vehicle models, serving as the exclusive supporting supplier for products such as electric seat switches and combination switches.Meanwhile, Wuling Motors pursued multiple breakthroughs in external markets, actively expanding its power battery product offerings and securing incremental market opportunities with OEMs such as Dongfeng Mengshi, FAW Jiefang, Chery Automobile, and Geely Automobile.A newly constructed and operational base in Jingmen, Hubei has seized the opportunity presented by Great Wall Motor’s production ramp-up to maintain rapid growth. In 2024, the base achieved revenue of approximately 729 million yuan, representing an exceeded 100% year-on-year increase; In terms of product development, the company completed the expansion of its second ultra-high-strength steel tube thermoforming production line within the year and successfully secured incremental customer orders from Great Wall Motor and BYD.Furthermore, Wuling Motors has successively undertaken the production of SAIC Maxus rear axles, BYD FinDreams Powertrain spiral bevel gears, and Dola Vehicle subframes, among other components, with the cumulative production and sales volume of new energy vehicle rear axles exceeding 1.5 million units. At the same time, Wuling Motors has actively capitalized on emerging opportunities in the new energy supporting market, successfully developing and optimizing products such as the new generation of new energy electric rear axles, integrated three-in-one motors and electric control systems, range extenders, power supply systems, and differential locks. Multiple new energy electric car axles have been successfully supplied for the electric drive axle and range extender projects of Great Wall Motor, JAC, and others. Notably, the first commercially deployed axial electric drive axle for the Changan Kaicene market has entered mass production.For the automobile power supply systems business, the division’s revenue for 2024 was approximately 1.74 billion yuan. Throughout the year, the power supply systems division maintained proactive communication with customers and enhanced its ability to manage planned orders, taking measures to reduce inventory and improve efficiency while ensuring customer demand was met. The casting business broke through adversity, continuing to expand its growth points, and successfully securing new market supply orders from the customer Changyuan Hero City, with the division’s total casting sales reaching 1.18 million units for the year, representing a 25% year-on-year increase.In addition, relying on the project platform management advantages, Wuling Motors’ power supply systems business focused on core projects such as the H15TD+DHT hybrid assembly architecture platform, the integrated three-in-one electric drive system, and high-pressure casting, to promote the construction of new energy projects with customers such as Skyworth, DFLZ, Zoomlion, and Senptec Electronics. It actively developed the new energy customer market with companies such as JAC, YC SIMLAN, Hebei Zhongxing, Geely Farizon, Chery Commercial Vehicles, Xpeng Motors, and Leapmotor. At the same time, it seized opportunities in overseas markets, with a focus on advancing projects such as the LJ481Q6 matching JAC M4 export (to Gulf countries), the overseas CLT flexible fuel hybrid project, and the Wuling Technology MSR project, to lay a solid foundation for overseas development.The commercial vehicles assembly business recorded a revenue of approximately 718 million yuan in 2024. Benefiting from the implementation of cost control measures, the operating profit reached approximately 75.92 million yuan. In line with the company’s strategy, the division continued to seek business breakthroughs in high-value-added niche markets.The development of the new energy vehicles business from the joint venture Wuling New Energy was favorable in 2024, achieving sales of over 14,000 units, a year-on-year increase of over 41%, and generating revenue of 1.02 billion, a year-on-year increase of 29.5%. Within the year, Wuling New Energy launched multiple products, and the Golden Mini Truck, which was launched in November, ranked third in the market for micro-small trucks with single rear wheels, positioning it among the top in the commercial vehicle market. Overseas, more than 800 units were exported to Japan and South Korea, representing a 58% year-on-year increase.Fully Supporting the Group’s Automobile Industry Ecosystem through New Growth Engines Created by Transformation and UpgradingWhile actively developing its core business, Wuling Motors is also undergoing continuous transformation and upgrading to expand into new businesses and foster new growth momentum. In 2024, Wuling Motors increased its investment in R&D to accelerate the development of its new energy business. The company also established an innovation center in Hong Kong and signed cooperation agreements with Hong Kong Polytechnic University, The Chinese University of Hong Kong, and the Hong Kong Applied Science and Technology Research Institute’s XR intelligent project to build an innovation ecosystem.2025 marks the inaugural year of the “LINXYS Project”, formulated by Guangxi Automobile Group Co., Ltd., the parent company of Wuling Motors, for the entire group. Guangxi Automobile Group plans to increase investment between 2025 and 2027 to fully promote the development blueprint centered around the “LINXYS Project” and the “131 Strategy”.The “131 Strategy” refers to 1 complete vehicle brand – the creation of the “Linxys” new energy vehicle brand; 3 national-level manufacturing champions: the national champion in small and medium displacement energy-efficient hybrid power systems, the national champion in lightweight drive axles, and the national champion in automotive frames; 1 automotive industry ecosystem: an automotive ecosystem led and operated by Guangxi Automobile Group.Mr. Yuan Zhijun, Chairman of Wuling Motors’ board of directors, stated, “The company will actively cooperate with Guangxi Automobile Group to accelerate the implementation of the ‘Linxys Project’ plan, speed up the conversion and application of scientific research results, improve the product portfolio, enhance product quality, actively expand domestic and overseas markets, and provide users with more valuable and environmentally friendly products. Under the leadership of the ‘Linxys Project’, the company is confident in achieving stable and positive operating results to allow shareholders to share in the development achievements.” Copyright 2025 ACN Newswire via SeaPRwire.com.
光大環境(00257)派息穩定增長 行業龍頭地位牢固
香港, 2025年3月28日 - (亞太商訊 via SeaPRwire.com) - 國內環保行業在政策、技術研發及市場擴張方面，正經歷全面格局重塑，在新格局下突圍需要新策略，需要深刻理解新的市場需求和行業運行邏輯。環保企業的成功不再依賴簡單的擴張，需要以更精細的策略實現突破，轉型與升級將成為關鍵節點。中國環保行業龍頭光大環境(00257.HK)在行業面臨較大的發展瓶頸背景下，去年仍實現穩健業績表現，派息見增長；謀劃「兩化一型」的發展策略，開啓「二次創業」，國內外市場拓展加快，可望迎來重估。派息比率提高 領先同業近日，光大環境公布截至2024年12月底止的全年業績，收益302.58億港元；其中，佔整體收益比重64%的運營服務收益約194.3億港元，同比增長1%，反映收入結構進一步優化。公司擬派末期息每股9港仙，較2023年度增長12.5%；全年股息達每股23港仙，全年派息率41.8%，較2023年度的30.5%大幅提升，反映集團對未來發展的信心，並於同業中領先。光大環境提供環境綜合服務，涵蓋各類環保項目的投資、建設和運營，產業鏈布局較為完整。集團鞏固傳統優勢主業同時，也積極探索新業務、新模式，加强產業鏈延伸與協同業務拓展，促進輕重資產業務平衡發展。2024年，光大環境共投資落實新項目12個，總投資約人民幣17.64億元；新簽署各類輕資產業務合同，合同總額約人民幣18.35億元。例如去年集團取得其首個儲能項目、首個生物質氣化項目和首個廢舊電池回收資源化利用項目，進一步拓寬業務範疇。海外市場方面，先後於埃及、印度尼西亞、馬來西亞、印度等地簽署或中標輕資產業務，進一步推動自主研發的環保裝備、工藝包出海。二次創業締造新增長引擎過去一年，光大環境深入調查研究，研判內外部形勢，制定「十五五」戰略發展預規劃，明確「兩化一型」（科技化、國際化、生態型）發展方向，開啓「二次創業」新征程。科技化方面，集團以新質生産力為指引，用科技創新引領産業創新，通過人工智能賦能企業治理，積極打造科研「生態圈」，以高科技實現高效能，助力高質量發展。國際化方面，集團以在新市場發揮傳統優勢，向海外輸出自身優勢業務、管理經驗和專業技術，穩步推進國際化發展進程。生態型方面，集團致力於通過耦合各類資源，促進將社會關係轉化為生産力，促進共贏共生，進而助力打造自身的高質量發展。截至2024年12月31日，光大環境業務分布已拓展至國內26個省（市）、自治區及特別行政區，足跡遍及229個市縣區，海外市場布局德國、波蘭、越南和毛里求斯；共投資落實環保項目604個，總投資約人民幣1,624.25億元。集團另承接環境修復、垃圾分類、設計諮詢、設備供貨、技術服務等各類輕資產服務。在深耕環保主業的同時，光大環境正以「兩化一型」戰略為引領，著力鞏固環保行業龍頭地位，以高質量發展步伐，開啓「二次創業」新征程，未來可望進一步迎來「質」的飛躍，前景值得留意。 Copyright 2025 亞太商訊 via SeaPRwire.com.
復星年度業績基本面穩健，未來增長路徑清晰
香港, 2025年4月1日 - (亞太商訊 via SeaPRwire.com) - 持續推進「瘦身健體，聚焦主業」的復星國際，3月30日公佈2024年全年業績。公告數據顯示，2024年復星國際（HKEX:0656）總收入達到人民幣1921.4億元，較2023年微降3.1%。其中，四大核心子公司豫園股份、復星醫藥、復星葡萄牙保險和復星旅文，總收入達到人民幣1346.5億元，佔集團總收入的比重達到70.1%。而因單體投資項目在報告期內一次性計提賬面損失，導致年度歸屬於母公司股東之虧損達到人民幣43.5億元。「過去一年，面對全球經濟波動和市場挑戰，我們保持穩健發展態勢，展現出了強勁的韌性。我們持續推動『聚焦主業，瘦身健體』的戰略調整，通過退出一些非主業資產及重資產，持續聚焦主業、降低負債並優化資產結構。過程中，由於單個項目帶來的賬面價值調整，影響了2024年的財務表現，但復星的整體運營基本面仍然穩健，核心產業依然健康發展，產業運營利潤和經營性現金流保持健康穩定。」復星國際董事長郭廣昌在致股東信中表示。中信證券根據復星國際業績情況，發表了研報，報告指出復星國際產業運營相對穩定，賬面價值調整導致虧損。事實上，剔除一次性非現金賬面減值因素影響，2024年復星國際歸母利潤約為人民幣7.5億元，而反映復星基本面成色及未來增長潛力的產業運營利潤更達到了人民幣49億元。與此同時，復星財務狀況保持穩健，截至2024年底，總債務佔總資本比率為52%，現金、銀行結餘及定期存款約為人民幣1063.4億元，較上一年度增加約人民幣138.8億元。健康的負債比率及厚實的現金流安全墊，不僅增強了抗風險能力，也提高了把握發展機會的能力。「我們始終相信，清晰的戰略聚焦和扎實的產業運營能力，是推動復星長期穩健發展的關鍵。」郭廣昌說。「有進有退」，深耕主業賽道去年以來，郭廣昌在多個公開場合用「有進有退」來概括復星正在執行的策略。他表示，過去幾年復星在「瘦身健體」過程中以「退」為主，但從2024年開始，更加強調「有進有退」，通過主業的「進」，用發展來解決問題。本次業績公告披露，2022年至2024年，復星三年累計完成非戰略、非核心資產退出約人民幣750億元等值。2024年，集團層面資產退出簽約約人民幣175億元等值，合併報表層面資產退出簽約約人民幣300億元等值。對非戰略、非核心資產持續而堅定的退出，不僅夯實了流動性安全墊，更有力支撐復星加速向大健康、旅遊文化、消費及保險等核心主業聚焦。2024年，復星圍繞核心主業持續進擊，動作頻頻。大健康方面，復星醫藥增持復星凱瑞權益至100%，持續聚焦腫瘤免疫細胞治療產品的研發、生產和商業化。旅遊文化方面，三亞超級地中海項目正式啟航，復星旅文深圳金沙灣輕資產運營簽約、大灣區首家Club Med落地；同時，復星旅文的太倉阿爾卑斯二期也即將動工，該度假區二期由太倉市政府平台打造，復星旅文運營管理。2025年3月，復星旅文順利完成私有化，未來將更靈活高效地加速輕資產轉型。從2024年財報數據看，貢獻復星超七成收入的四大核心子公司表現不俗。其中，復星醫藥實現營業收入人民幣410.67億元，歸母淨利潤人民幣27.70億元，同比增加16.08%。復星葡萄牙保險全年毛保費總額為61.72億歐元，淨利潤達1.735億歐元。復星旅文連續保持盈利，Club Med錄得營業額約人民幣161.5億元，再創歷史新高，三亞亞特蘭蒂斯全年營業額保持高位。在國內消費結構調整大環境下業務承壓的豫園股份，通過主動調整，資產負債率下降至67.82%，在手貨幣現金充沛，達人民幣106.9億元，為未來發展蓄力。值得一提的是，經過多年積累和深耕，復星旗下兩家境內保險公司也迎來了高速發展機遇期。復星保德信人壽的總保費收入從2023年的人民幣43.46億元大幅增長至2024年的人民幣92.51億元，復星聯合健康保險的保費收入也穩步提升，並且兩家公司都實現了盈利。2024年，整個保險板塊歸屬於母公司股東之利潤為人民幣17.16億元，同比大幅提升117%。「我們將復星對產業的深度理解、投資的豐富經驗以及的優質的商業資源與保險公司的運營和投資相結合，形成了一個多維度賦能的『保險+產業+投資』立體飛輪驅動戰略。」郭廣昌認為，旗下境內外保險公司和各產業的共同成長，無疑為復星的「飛輪戰略」奠定了強有力的支撐。「全球化+創新」，核心能力加速價值釋放復星能夠在進退之間，錨定主業行穩致遠，得益於兩大核心能力：全球化和創新。2024年，復星繼續深化在全球超過35個國家和地區的產業佈局，夯實全球深度運營能力，全年海外收入在高基數基礎上，實現同比增長6.2%，達人民幣947.8億元，佔總收入的比重進一步上升至49.3%。在逆全球化風潮下，復星的全球化能力愈發凸顯出稀缺性，而高質量的全球化業務，也正成為復星新一輪增長的強勁引擎。2024年，復星創新生物藥平台 - 復宏漢霖成為中國創新藥出海的明星企業。報告期內，復宏漢霖海外產品銷售收入較上一年度大幅增長30.76%。自主研發的全球首個用於一線治療小細胞肺癌的抗PD-1單抗漢斯狀，獲得歐盟批准上市，觸達國家和地區增至30多個；漢曲優在美國和加拿大獲批准上市，開啟北美商業化新征程；中國首款生物類似藥漢利康在秘魯等多個拉丁美洲國家獲批上市；漢貝泰也首次於玻利維亞獲批上市。目前，復宏漢霖已有四款自主研發的產品在海外獲批上市。得益於核心產品市場持續擴大，復宏漢霖2024年實現營業收入約人民幣57.244億元，淨利潤達8.205億元，同比大增50.3%。依託復星全球生態，海南礦業也加速全球資源佈局，連續三年實現每年落地1個海外項目併購。報告期內，海南礦業獲得阿曼蘇丹國4個區塊的油田權益，並啟動了對非洲莫桑比克兩個在產鋯鈦礦的併購，擬進一步加大在非洲的投資佈局，切入前景廣闊的小金屬及稀土行業。此外，截至2025年3月，非洲馬里布穀尼鋰礦一期已具備連續穩定生產條件。2024年，海南礦業境外子公司營收人民幣19.68億元，佔比提升至48%。在全球化戰略驅動下，實現歸母淨利潤7.06億元，同比增長12.97%，扣非淨利潤6.80億元，同比大增23.72%。海外成員企業中，復星葡萄牙保險在持續鞏固本土市場領先地位的同時，充分發揮復星「全球組織+本地運營」能力，國際業務實現雙位數增長。2024年實現海外收入達18.4億歐元，國際業務佔比提升至29.8%。復星標誌性文化IP豫園燈會，繼2023年底至2024年初首次走出國門在巴黎綻放後，2025年再度揚帆海外，1月豫園燈會主題燈組驚豔亮相越南河內，年內還將亮相泰國，持續向世界展示東方文化魅力。在郭廣昌看來，創新與全球化相輔相成，是復星最重要的基因。2024年，復星科創投入達約人民幣69億元，目前已建立超過20家全球科創中心，覆蓋多個行業領域，持續賦能新技術、新產品落地。創新藥研發方面，2024年復星醫藥自主研發及許可引進的7個創新藥/生物類似藥共16項適應症獲批上市。醫療器械與醫學診斷方面，直觀復星的Ion系統、復星醫藥自主研發的F-i6000全自動化學發光免疫分析儀、F-C2000全自動高速化學發光分析儀、細胞因子檢測試劑（化學發光法）分別在國內獲批上市分別在國內獲批上市。報告期內，復星醫藥製藥板塊專利申請達220項，其中包括美國專利申請3項、PCT申請18項；獲得發明專利授權66項。面對方興未艾的AI浪潮，復星圍繞核心業務加速佈局，將AI技術深度融入到豐富的業務場景中，以推動創新及效率提升。例如，復星醫藥推出PharmAID決策智能體平台，可支持精準高效決策，助力藥物研發提速增效；復銳醫療探索利用AI精準分析用戶皮膚，提供個性化護理方案；超級地中海項目打造全球首個AI主題度假區，通過AIGC技術實現客房個性化定制，並將引入數字人G.O（快樂管家）服務，提升遊客體驗。「未來，我們將繼續深耕核心產業，依託全球化能力和創新驅動力，我們有信心保持穩健發展，為股東創造長期、穩定的價值。」郭廣昌說。 Copyright 2025 亞太商訊 via SeaPRwire.com.